TerminatedNCT01340690
Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder
Placebo comparisonAges 6–17GermanyADHD
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.
- Listed locations
- Bad Neuenahr and 4 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 8, 2011
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 284
- Sponsor
- Johannes Gutenberg University Mainz
- Sponsor type
- University
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Germany
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT01340690
- Official title
Show the full official title
PAD-study: Nutritional Efficacy of Polyunsaturated Fatty Acids (Omega-3 and Omega-6) in Combination With Zinc and Magnesium Versus Placebo in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder (ADHD)
Recruitment & locations
TerminatedBad Neuenahr · Berlin · Mainz
2 more locations
- Maulbronn
- Neuwied
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Johannes Gutenberg University Mainz, a university.
Who can participate?
This study is for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)
Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents...